Type 2 diabetes is a chronic metabolic disease that results from insulin resistance in the liver, muscle, and adipose tissue and relative insulin deficiency. The endoplasmic reticulum (ER) plays a crucial role in the regulation of the cellular response to insulin. Recently, ER stress has been known to reduce the insulin sensitivity of the liver and lead to type 2 diabetes. However, detailed mechanisms of ER stress response that leads to type 2 diabetes remains unknown. To obtain a global view of ER function in type 2 diabetic liver and identify proteins that may be responsible for hepatic ER stress and insulin resistance, we performed proteomics analysis of mouse liver ER using nano UPLC-MS E. A total of 1584 proteins were identified in control C57 and type 2 diabetic db/db mice livers. Comparison of the rER and sER proteomes from normal mice showed that proteins involved in protein synthesis and metabolic process were enriched in the rER, while those associated with transport and cellular homeostasis were localized to the sER. In addition, proteins involved in protein folding and ER stress were found only in the rER. In the livers of db/db mice, however, the functions of the rER and sER were severely disrupted, including the capacity to resolve ER stress. These results provide new insight into the research on hepatic insulin resistance and type 2 diabetes and are suggestive of the potential use of the differentially expressed hepatic ER proteins as biomarkers for hepatic insulin resistance and type 2 diabetes.
References
[1]
Vertel, B.M.; Walters, L.M.; Mills, D. Subcompartments of the endoplasmic reticulum. Semin. Cell Biol 1992, 3, 325–341.
[2]
English, A.R.; Zurek, N.; Voeltz, G.K. Peripheral ER structure and function. Curr. Opin. Cell Biol 2009, 21, 596–602.
[3]
Voeltz, G.K.; Rolls, M.M.; Rapoport, T.A. Structural organization of the endoplasmic reticulum. EMBO Rep 2002, 3, 944–950.
[4]
Ozcan, L.; Tabas, I. Role of endoplasmic reticulum stress in metabolic disease and other disorders. Annu. Rev. Med 2012, 63, 317–328.
[5]
Yoshida, H. ER stress and diseases. FEBS J 2007, 274, 630–658.
[6]
Dara, L.; Ji, C.; Kaplowitz, N. The contribution of endoplasmic reticulum stress to liver diseases. Hepatology 2011, 53, 1752–1763.
[7]
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26, S5–S20.
[8]
Lebovitz, H.E. Type 2 diabetes: An overview. Clin. Chem 1999, 45, 1339–1345.
[9]
Kahn, S.E.; Hull, R.L.; Utzschneider, K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444, 840–846.
[10]
DeFronzo, R.A.; Simonson, D.; Ferrannini, E. Hepatic and peripheral insulin resistance: A common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1982, 23, 313–319.
[11]
Paquot, N.; Scheen, A.J.; Dirlewanger, M.; Lefebvre, P.J.; Tappy, L. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients. Obes. Res 2002, 10, 129–134.
[12]
Samuel, V.T.; Shulman, G.I. Mechanisms for insulin resistance: Common threads and missing links. Cell 2012, 148, 852–871.
[13]
Flamment, M.; Hajduch, E.; Ferre, P.; Foufelle, F. New insights into ER stress-induced insulin resistance. Trends Endocrinol. MeTable 2012, 23, 381–390.
[14]
Sundsten, T.; Ortsater, H. Proteomics in diabetes research. Mol. Cell. Endocrinol 2009, 297, 93–103.
[15]
Sanchez, J.C.; Converset, V.; Nolan, A.; Schmid, G.; Wang, S.; Heller, M.; Sennitt, M.V.; Hochstrasser, D.F.; Cawthorne, M.A. Effect of rosiglitazone on the differential expression of obesity and insulin resistance associated proteins in lep/lep mice. Proteomics 2003, 3, 1500–1520.
[16]
Edvardsson, U.; von Lowenhielm, H.B.; Panfilov, O.; Nystrom, A.C.; Nilsson, F.; Dahllof, B. Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator-activated receptor activators. Proteomics 2003, 3, 468–478.
[17]
Schmid, G.M.; Converset, V.; Walter, N.; Sennitt, M.V.; Leung, K.Y.; Byers, H.; Ward, M.; Hochstrasser, D.F.; Cawthorne, M.A.; Sanchez, J.C. Effect of high-fat diet on the expression of proteins in muscle, adipose tissues, and liver of C57BL/6 mice. Proteomics 2004, 4, 2270–2282.
[18]
Baiges, I.; Palmfeldt, J.; Blade, C.; Gregersen, N.; Arola, L. Lipogenesis is decreased by grape seed proanthocyanidins according to liver proteomics of rats fed a high fat diet. Mol. Cell. Proteomics 2010, 9, 1499–1513.
[19]
Valle, A.; Catalan, V.; Rodriguez, A.; Rotellar, F.; Valenti, V.; Silva, C.; Salvador, J.; Fruhbeck, G.; Gomez-Ambrosi, J.; Roca, P.; Oliver, J. Identification of liver proteins altered by type 2 diabetes mellitus in obese subjects. Liver Int 2012, 32, 951–961.
[20]
Song, Y.; Hao, Y.; Sun, A.; Li, T.; Li, W.; Guo, L.; Yan, Y.; Geng, C.; Chen, N.; Zhong, F.; et al. Sample preparation project for the subcellular proteome of mouse liver. Proteomics 2006, 6, 5269–5277.
[21]
Song, Y.; Jiang, Y.; Ying, W.; Gong, Y.; Yan, Y.; Yang, D.; Ma, J.; Xue, X.; Zhong, F.; Wu, S.; et al. Quantitative proteomic survey of endoplasmic reticulum in mouse liver. J. Proteome Res 2010, 9, 1195–1202.
[22]
Hummel, K.P.; Dickie, M.M.; Coleman, D.L. Diabetes, a new mutation in the mouse. Science 1966, 153, 1127–1128.
[23]
Matsuda, T.; Kido, Y.; Uchida, T.; Kasuga, M. Reduced insulin signaling and endoplasmic reticulum stress act synergistically to deteriorate pancreatic beta cell function. Kobe J. Med. Sci 2008, 54, E114–E121.
Hummasti, S.; Hotamisligil, G.S. Endoplasmic reticulum stress and inflammation in obesity and diabetes. Circ. Res 2010, 107, 579–591.
[26]
Van der Kallen, C.J.; van Greevenbroek, M.M.; Stehouwer, C.D.; Schalkwijk, C.G. Endoplasmic reticulum stress-induced apoptosis in the development of diabetes: Is there a role for adipose tissue and liver? Apoptosis 2009, 14, 1424–1434.
[27]
Lin, J.H.; Li, H.; Yasumura, D.; Cohen, H.R.; Zhang, C.; Panning, B.; Shokat, K.M.; Lavail, M.M.; Walter, P. IRE1 signaling affects cell fate during the unfolded protein response. Science 2007, 318, 944–949.
[28]
Wang, Y.; Vera, L.; Fischer, W.H.; Montminy, M. The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis. Nature 2009, 460, 534–537.
[29]
Han, M.S.; Chung, K.W.; Cheon, H.G.; Rhee, S.D.; Yoon, C.H.; Lee, M.K.; Kim, K.W.; Lee, M.S. Imatinib mesylate reduces endoplasmic reticulum stress and induces remission of diabetes in db/db mice. Diabetes 2009, 58, 329–336.
[30]
Morand, J.P.; Macri, J.; Adeli, K. Proteomic profiling of hepatic endoplasmic reticulum-associated proteins in an animal model of insulin resistance and metabolic dyslipidemia. J. Biol. Chem 2005, 280, 17626–17633.
[31]
Ni, M.; Lee, A.S. ER chaperones in mammalian development and human diseases. FEBS Lett 2007, 581, 3641–3651.
[32]
Malhi, H.; Kaufman, R.J. Endoplasmic reticulum stress in liver disease. J. Hepatol 2011, 54, 795–809.
[33]
Yamagishi, N.; Ueda, T.; Mori, A.; Saito, Y.; Hatayama, T. Decreased expression of endoplasmic reticulum chaperone GRP78 in liver of diabetic mice. Biochem. Biophys. Res. Commun 2012, 417, 364–370.
[34]
Li, T.; Woods, J.S. Cloning, expression, and biochemical properties of CPOX4, a genetic variant of coproporphyrinogen oxidase that affects susceptibility to mercury toxicity in humans. Toxicol. Sci 2009, 109, 228–236.
[35]
Wang, W.A.; Groenendyk, J.; Michalak, M. Calreticulin signaling in health and disease. Int. J. Biochem. Cell Biol 2012, 44, 842–846.
[36]
Williams, D.B. Beyond lectins: The calnexin/calreticulin chaperone system of the endoplasmic reticulum. J. Cell Sci 2006, 119, 615–623.
[37]
Christensen, A.; Svensson, K.; Persson, S.; Jung, J.; Michalak, M.; Widell, S.; Sommarin, M. Functional characterization of Arabidopsis calreticulin1a: A key alleviator of endoplasmic reticulum stress. Plant Cell Physiol 2008, 49, 912–924.
[38]
Huang, J.; Viswakarma, N.; Yu, S.; Jia, Y.; Bai, L.; Vluggens, A.; Cherkaoui-Malki, M.; Khan, M.; Singh, I.; Yang, G.; et al. Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice. Am. J. Pathol 2011, 179, 703–713.
Wang, B.; Zhou, S.F. Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr. Med. Chem 2009, 16, 4066–4218.
[41]
Shimojo, N. Cytochrome P450 changes in rats with streptozocin-induced diabetes. Int. J. Biochem 1994, 26, 1261–1268.
[42]
Wang, Z.; Hall, S.D.; Maya, J.F.; Li, L.; Asghar, A.; Gorski, J.C. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. Br. J. Clin. Pharmacol 2003, 55, 77–85.
Moon, Y.J.; Kwon, J.; Yun, S.H.; Lim, H.L.; Kim, M.S.; Kang, S.G.; Lee, J.H.; Choi, J.S.; Kim, S.I.; Chung, Y.H. Proteome Analyses of Hydrogen-producing Hyperthermophilic Archaeon Thermococcus onnurineus NA1 in Different One-carbon Substrate Culture Conditions. Mol. Cell. Proteomics 2012, 11, doi:10.1074/mcp.M111.015420.
[45]
Ingenuity Pathway Analysis, Available online: http://www.ingenuity.com , accessed on 27 September 2012.
[46]
GOfact. Available online: http://61.50.138.118/gofact/cgi/gofact2009.cgi , accessed on 27 September 2012.
[47]
Park, E.C.; Cho, G.S.; Kim, G.H.; Choi, S.C.; Han, J.K. The involvement of Eph-Ephrin signaling in tissue separation and convergence during Xenopus gastrulation movements. Dev. Biol 2011, 350, 441–450.
